FLSM
IMCR icon

Frazier Life Sciences Management’s Immunocore IMCR Stock Holding History

Frazier Life Sciences Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6M Buy
484,782
+100,000
+26% +$3.24M 0.38% 30
2025
Q4 		$13.4M Hold
384,782
– – 0.36% 33
2025
Q3 		$14M Hold
384,782
– – 0.42% 35
2025
Q2 		$12.1M Buy
384,782
+83,612
+28% +$2.6M 0.48% 37
2025
Q1 		$8.94M Buy
301,170
+192,408
+177% +$5.77M 0.41% 32
2024
Q4 		$3.21M Hold
108,762
– – 0.13% 50
2024
Q3 		$3.39M Hold
108,762
– – 0.14% 50
2024
Q2 		$3.69M Buy
+108,762
New +$5.55M 0.17% 47

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return